SecBot SecBot
EFFECT ·Filed Apr 13, 2026

GALT

GALECTIN THERAPEUTICS INC
NEUTRAL
Impact 3/10
Horizonweeks Processed6mo ago SEC9999999995-26-001150
IPO/offering going effective
Actionable Insight • Neutral

Monitor for future prospectus supplements indicating actual sales under the shelf or ATM program, which could lead to near-term dilution. The effectiveness itself does not raise capital but enables future offerings.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
GALT ▲ +91.91% at T+60d
NEUTRAL call +91.91% · α vs SPY +82.99% · entry $2.35 → $4.51
Entry = T+0 close
Apr 13, 2026
via day close
T+1d
+5.11%
call +5.11% · α +3.90%
$2.47
settled 7mo ago
T+5d
-2.55%
call -2.55% · α -5.85%
$2.29
settled 6mo ago
T+20d
-5.96%
call -5.96% · α -13.69%
$2.21
settled 6mo ago
T+60d
+91.91%
call +91.91% · α +82.99%
$4.51
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Galectin Therapeutics' shelf registration (Form S-3) has become effective, allowing the company to raise up to $200 million through future sales of common stock, warrants, or rights. This includes a pre-arranged $32.5 million at-the-market (ATM) offering program.

Key Facts

  • Shelf registration Form S-3 (File No. 333-294782) became effective on April 10, 2026.
  • Allows issuance of up to $200 million in common stock, warrants, and rights over time.
  • Includes a $32.5 million ATM program with H.C. Wainwright & Co. established on May 11, 2020.
  • No immediate fundraising; securities may be offered continuously or intermittently based on market conditions.

Financial Impact

Up to $200 million in potential future dilution; up to $32.5 million available immediately via ATM.

dilutionequitycash

Risk Factors

  • Potential share dilution if offerings proceed under the shelf or ATM program.
  • Market perception of equity overhang may pressure the stock despite no immediate issuance.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-001150
Document: 9999999995-26-001150-index.html9999999995-26-001150
Document: 9999999995-26-001150.txt9999999995-26-001150
11 reports for GALT
Performance horizon
100% Hit rate @ T+20 3 of 3 directional calls Went positive at some point 4 of 5 best @ T+60▲ +44.24%May 15, 2026
Filters
Rows
Reports for GALT — sortable, filterable
TypeNow
Oct 13, 2026
13d ago
DEFA14A
NEUTRAL ★ 5/10
$3.69awaiting T+20—$3.19 (−13.55%)
Oct 13, 2026
13d ago
DEF 14A
BEARISH ★ 6/10
$3.69awaiting T+20—$3.19 (+13.55%)
Oct 6, 2026
20d ago
Press Release
BULLISH ★ 7/10
$3.76awaiting T+20—$3.19 (−15.16%)
Aug 14, 2026
10w ago
Press Release
BULLISH ★ 8/10
$3.44 $3.84▲ +11.63%▲ +13.62%$3.19 (−7.27%)
Aug 14, 2026
10w ago
8-K
BULLISH ★ 8/10
$3.44 $3.84▲ +11.63%▲ +13.62%$3.19 (−7.27%)
Aug 4, 2026
11w ago
8-K
MIXED ★ 7/10
$2.99 $4.17▲ +39.46%▲ +40.70%$3.19 (+6.69%)
Jun 30, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$4.33 $3.49▼ −19.40%▼ −17.21%$3.19 (−26.33%)
May 15, 2026
23w ago
Press Release
BULLISH ★ 6/10
$2.17 $2.62▲ +20.74%▲ +18.62%$3.19 (+47.00%)
May 15, 2026
23w ago
8-K
NEUTRAL ★ 5/10
$2.17 $2.62▲ +20.74%▲ +18.62%$3.19 (+47.00%)
Apr 13, 2026
28w ago
EFFECT
NEUTRAL ★ 3/10
$2.35 $2.21▼ −5.96%▼ −13.69%$3.19 (+35.74%)
Showing 10 of 11

US Market Status

Market Closed — Opens in 3h 16m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 13, 2026